MedAvail Inc. (MDVL)
NASDAQ: MDVL
· Real-Time Price · USD
1.80
-1.37 (-43.22%)
At close: Feb 12, 2024, 10:00 PM
MedAvail Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 405K | 620K | 11.35M | 11.46M | 11.18M | 9.11M | 7.28M | 5.79M | 5.03M | 4.03M |
Cost of Revenue | 227K | 363K | 11.48M | 10.17M | 10.27M | 8.61M | 7.64M | 5.61M | 4.86M | 3.71M |
Gross Profit | 178K | 257K | -126K | 1.29M | 918K | 501K | -362K | 186K | 173K | 320K |
Operating Income | -4.45M | -5.01M | -10.74M | -11.49M | -11.42M | -12.77M | -12.37M | -11.03M | -10.46M | -9.65M |
Interest Income | 146K | 1K | 1K | 315K | n/a | 1K | 5K | 7K | 27K | 40K |
Pretax Income | -5.5M | -12.56M | -11.07M | -11.81M | -11.69M | -13.02M | -12.63M | -11.27M | -10.46M | -9.45M |
Net Income | -5.79M | -17.5M | -11.07M | -12.12M | -11.72M | -13.28M | -12.63M | -11.27M | -10.46M | -9.45M |
Selling & General & Admin | 4.43M | 5.09M | 6.52M | 11.11M | 8.41M | 12.28M | 7.69M | 10.19M | 9.86M | 7.89M |
Research & Development | 145K | 176K | 163K | 178K | 281K | 493K | 248K | 232K | 201K | 168K |
Other Expenses | n/a | n/a | 3.94M | 1.5M | 3.65M | 501K | -161K | 7K | 38K | 161K |
Operating Expenses | 4.63M | 5.27M | 10.62M | 12.78M | 12.34M | 13.27M | 12.01M | 11.21M | 10.64M | 9.97M |
Interest Expense | 146K | 169K | 327K | 315K | 276K | 254K | 261K | 260K | 66K | 2K |
Selling & Marketing Expenses | 10K | 132K | 1.75M | 166K | 2.31M | 2.31M | 2.15M | 1.78M | 1.5M | 1.38M |
Cost & Expenses | 4.86M | 5.63M | 22.09M | 22.95M | 22.6M | 21.88M | 19.65M | 16.82M | 15.49M | 13.68M |
Income Tax Expense | 295K | 4.94M | -1K | 315K | 24K | 253K | -4K | 2K | 104K | n/a |
Shares Outstanding (Basic) | 1.8M | 1.61M | 1.61M | 1.57M | 1.39M | 658.44K | 657.04K | 655.02K | 650.93K | 648.8K |
Shares Outstanding (Diluted) | 1.8M | 1.61M | 1.61M | 1.6M | 1.39M | 658.44K | 657.04K | 655.02K | 650.93K | 648.8K |
EPS (Basic) | -3.22 | -10.9 | -6.9 | -7.7 | -8.46 | -20.16 | -19.22 | -17.21 | -16.08 | -14.57 |
EPS (Diluted) | -3.22 | -10.9 | -6.9 | -7.57 | -8.45 | -20.16 | -19.22 | -17.21 | -16.08 | -14.57 |
EBITDA | -5.5M | -12.56M | -10.74M | -9.71M | -10.75M | -12.17M | -11.6M | -10.27M | -9.83M | -9.15M |
EBIT | -5.35M | -12.39M | -10.74M | -11.49M | -15.07M | -16.7M | -12.37M | -11.01M | -10.4M | -9.45M |
Depreciation & Amortization | 431K | 1K | 1K | 1.78M | 654K | 599K | 772K | 739K | 564K | 502K |